Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-01

FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for levocetirizine dihydrochloride from Marlex Pharmaceuticals Inc, indicating an approved regulatory update for this pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

SUPPL AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)